Showing 1 - 20 results of 20 for search 'R. A. Murashko', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative b... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, E. V. Lymar
Published 2022-06-01
Article -
9
-
10
-
11
-
12
Russian multicenter experience of robot-assisted surgery in patients with rectal cancer by D. V. Gladyshev, B. N. Kotiv, A. M. Belyaev, A. M. Karachun, R. A. Murashko
Published 2017-12-01
Article -
13
-
14
Analysis of the clinical efficacy of the cyclin- dependent kinase inhibitor 4/6 Abemaciclib on the clinical case of a male with hormonereceptor- positive breast cancer by А. Y. Goryainova, А. I. Stukan, Е. V. Lymar, S. V. Sharov, R. A. Murashko, D. V. Andreev
Published 2021-06-01
Article -
15
Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibit... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar
Published 2021-12-01
Article -
16
-
17
-
18
-
19
-
20
Clinical and prognostic characteristics of <I>BRCA1/2</I>-associated breast cancer depending on the type of mutation: estrogen signaling pathway and secondary tumors by A. I. Stukan, A. Yu. Goryainova, R. A. Murashko, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko, O. A. Goncharova, E. N. Imyanitov, V. A. Porkhanov
Published 2022-09-01
Article